Scroll for more

blog

Jun 21, 2018 benevolentai

BenevolentAI Awarded Technology Pioneer Status by World Economic Forum

Every year, the World Economic Forum welcomes leading early-stage technology companies from around the world into its Technology Pioneer’s community. In its own words, these companies are “poised to have a significant impact on business and society”. Today we are delighted and humbled to be named as one such Technology Pioneer.

Jun 11, 2018 benevolentai

The Long Read – Thinking Deep on the Future of AI

Joanna Shields gives the opening speech at CogX 2018 event about "Why AI matters to us all"

May 2, 2018 benevolentai

A new chapter @ BenevolentAI

Today marks my first official day as Group CEO at BenevolentAI. For me, it is the next step of a journey, one that has encompassed amazing experiences building some of the biggest technology brands on the planet. Yet none of them had the same potential to transform our lives for the better as we have here at BenevolentAI.

Apr 17, 2018 jackie hunter

Blurring of the physical, digital and biological boundaries

The beginning of the year has been incredibly busy here at BenevolentAI - I am sure over the coming weeks and months you'll be hearing more on this - it is an incredibly exciting time. Despite the frenetic activity I try to make the effort to read around new and interesting publications in the digital healthcare space.

Mar 29, 2018 benevolentai

RESEARCH | Planning chemical syntheses with deep neural networks and symbolic AI

Marwin Segler, senior machine learning researcher at BenevolentAI, shows in his Nature paper how AI can transform the success rate of planning the synthesis of organic molecules – so-called retrosynthesis.

Mar 27, 2018 benevolentai

RESEARCH | Exploring deep recurrent models with reinforcement learning for molecule design

The design of small molecules with bespoke properties is of central importance to drug discovery. However significant challenges yet remain for computational methods, despite recent advances such as deep recurrent networks and reinforcement learning strategies for sequence generation, and it can be difficult to compare results across different works.

Mar 1, 2018 benevolentai

A view from the labs

A new view brings a new perspective… …its late February and I am sitting in our new Cambridge office looking at an unusually snowy scene of lawns and woodland.

Jan 16, 2018 benevolentai

What if AI could take your research to the next level?

Most scientific breakthroughs are made by analysing data, but we live in a world where the exponential growth of scientific research data makes the discovery of new drugs and treatments for disease very difficult. 

Nov 2, 2017 jackie hunter

The AI Industry Must Embrace Diversity Or Risk Reinforcing The Status Quo

Professor Jackie Hunter, CEO of BenevolentBio, writes for The Huffington Post on diversity in the AI industry and how it has the chance to embrace it or risk going the same way as many other industries.

Oct 5, 2017 jackie hunter

Why it’s essential the AI sector reflects society at large

Jackie Hunter explains why we need to encourage diversity in AI in a co-ordinated effort across the home, at school, at university and into the workplace.

Oct 3, 2017 benevolentai

Are You Looking For A Faster Horse In Drug Discovery?

As we all work busily in our own corners of drug discovery, be it in Pharma, biotech or academia, ask yourself the question – are you just pushing that horse a little more or are you genuinely imagining and creating the model T of the 21st century?

May 31, 2017 benevolentai

Join the special interest group on artificial intelligence in biomedicine.

Initiated after the first Artificial Intelligence (AI) in Bioscience Symposium in 2016, the special interest group on AI in Biomedicine aims at stimulating debate and encouraging collaboration between experts in life science and AI.

Jan 11, 2017 kenneth mulvany

Is AI morality asleep at the wheel?

In an age where you could soon be legally (and safely) asleep at the wheel thanks to driverless cars will morality in AI go the same way – is the principle of ethics in AI asleep at the wheel?

Nov 5, 2016 jackie hunter

In five years' time… Key trends in AI healthcare

10 years ago I attended a symposium looking at the future of pharmacology and healthcare.

Oct 7, 2016 jackie hunter

What happens when you put expert human brains in a room to discuss machine brains?

These are truly exciting times for artificial intelligence (“AI”) and bioscience. This month, together with The Crick and Turing Institutes and the Wellcome Trust, we co-hosted the first of what we anticipate will be an annual symposium on ‘Artificial Intelligence in Bioscience’.